人类首次成功研制“艾滋疫苗” 感染率下降31%


人类首次成功研制“艾滋疫苗” 感染率下降31%

 
 
 
 
 

人类首次成功研制“艾滋疫苗” 感染率下降31%
http://www.dayoo.com http://www.dayoo.com 2009-10-02 06:55 来源: 法制晚报


  人类首次成功研制“艾滋疫苗”

  美泰两国合作开发 此疫苗可使艾滋病感染率降31.2% 世卫组织称结果“令人鼓舞”

  据美国媒体报道,美国和泰国研究人员24日共同宣布,双方合作开发试验的一种“联合疫苗”可以将人体感染艾滋病病毒的风险降低31.2%。

  这是人类首次获得具有免疫效果的艾滋病疫苗。

  试验证明艾滋病疫苗有效

  据报道,这种“联合疫苗”由两种疫苗组成,其中一种负责刺激免疫系统,第二种则负责增强免疫反应。

  “联合疫苗”试验始于2003年10月,试验对象是在泰国选取的1.6万多名年龄在18岁至30岁的志愿者,其艾滋病病毒检测均为阴性。

  结果显示,在8197名接受疫苗注射的志愿者中,51人感染了艾滋病病毒,而在对照组的8198人中,有74人感染,即注射疫苗组感染风险降低了31.2%。

  此前疫苗研发“屡战屡败”

  在此之前,还没有任何一种疫苗能取得这样的免疫效果。自1983年人类发现艾滋病病毒以后的近30年间,各国科研人员在开发艾滋病疫苗方面可谓“屡战屡败”。

  统计数据显示,2007年全球有200万人死于艾滋病,而目前每天新增的艾滋病病毒感染人数多达7500人。有科学家甚至一度认为,人类可能永远无法找到有效的艾滋病疫苗。

  意义重大首次证明疫苗可防艾滋病

  此次,美国和泰国研究人员完成的是迄今最大规模的艾滋病疫苗试验,且取得“突破性”结果,美国媒体报道称,这表明,成功研发出有效的艾滋病疫苗完全可能,人类击败“世纪瘟疫”大有希望。

  世界卫生组织和联合国艾滋病规划署当天发表联合声明表示,由美国和泰国开发试验的新型艾滋病疫苗获得的结果“令人鼓舞”,这一代表重大科学进步的试验结果首次表明,通过疫苗是可以在普通成年人中预防感染艾滋病病毒的,其意义重大。

  不过,参与研究的美国国家过敏和传染病研究所所长安东尼·福奇审慎地说,这并非“终点”,他对进一步提高疫苗的免疫效果表示乐观。

  综合报道/记者刘晓雪
 

The first successful human development of the "HIV vaccine" infection rates decreased by 31%
http://www.dayoo.com http://www.dayoo.com 2009-10-02 06:55 Source: Legal Evening News


The first successful human development of the "AIDS vaccine"

The United States and Thailand between the two countries to develop this new vaccine can lower HIV infection rates 31.2% of the WHO, said the results "encouraging"

According to U.S. media reports, the U.S. and Thai researchers announced on the 24th, the two sides co-development and testing of a "vaccine" can the human body reduce the risk of HIV infection 31.2%.

This is the first time with the immune effect of the human AIDS vaccine.

Proved an effective AIDS vaccine trial

It is reported that this "combined vaccine" formed by the two vaccines, one of which is responsible for stimulating the immune system, the second is responsible for the enhanced immune response.

"Combined vaccine" trial began in October 2003 the test object is selected in Thailand, more than 16000 aged 18 to 30 years old volunteers, their HIV testing were negative.

The results showed that in 8197 vaccinated volunteers, 51 people were infected with HIV, while in the control group of 8198 people, 74 people infected, or vaccinated group 31.2% lower risk of infection.

Prior to vaccine development, "conspicuous failure"

Prior to this, there is no vaccine can achieve such an immune effect. Since 1983, the human AIDS virus was found after nearly 30 years, countries in the development of AIDS vaccine researchers, has a "conspicuous failure."

Statistics show that in 2007 the world's 200 million people died of AIDS, and the present day, the number of new HIV infections up to 7500 people. Some scientists have even said that human beings may never be able to find an effective AIDS vaccine.

The first demonstration of significant anti-AIDS vaccine

This time, the United States and Thailand, researchers accomplished is by far the largest HIV vaccine trial, and to achieve a "breakthrough" results, the U.S. media reported, which indicates that successfully developed an effective HIV vaccine may well, human beat "century plague "promising.

World Health Organization and UNAIDS issued a joint statement the same day by the United States and Thailand, development and testing of new AIDS vaccine results "encouraging", the representatives of major scientific progress in test results for the first time that vaccine can be In the average adult HIV infection prevention, and its great significance.

However, participated in the study of the U.S. National Institute of Allergy and Infectious Diseases Director Anthony Fauci careful to say that this is not the "finish", he further enhance the immune effect of the vaccine expressed optimism.

Roundup / reporter Xiao-Xue Liu
 
 
 
 
 
 

[ 作者:佚名    转贴自:本站原创    点击数:197    更新时间:2009-10-2    文章录入:nnb ]

 

艾滋病或不再是绝症

 

 

价值中国网网友关注“发明艾滋病新药免费救治征集媒体见证人”

艾滋病早期治疗是康复与延长30~60年生命的保障

鸡尾酒疗法并非万能,抗药性与毒副作用导致联合疗法与中药疗法应用的迫切性

呼吁救治艾滋,关注化学新药

康生丹配合西药治疗AIDS总结

艾滋病“感染”、“免疫”与“营养”三关各期施治研究

康生丹四代新药,化学名—三合皂甙分类引述
 

艾滋病免疫重建的重要意义是挽救生命的根本 

从食品植物研究开发的治疗艾滋病新药三合皂甙〔康生丹四代〕介绍  

从食品植物研究开发的治疗艾滋病新药三合皂甙  

从食品植物研究开发的治疗艾滋病新药介绍  

艾滋病的中药  

论HIV不是AIDS的病因机制 

康生丹颗粒简介 

美国营养学家推崇“抗炎饮食”同于中医之食疗 

康生丹颗粒基础研究 

艾滋病预防及国外食疗研究 

艾滋病感染者能活多久 

专家:艾滋病早治疗能多活30年以上“隐形”感染者进入晚期才被确诊 

T细胞、T细胞亚群、 调节性(或抑制性)T细胞在艾滋病康复中的研究 

你知道为什么害怕“艾滋病”这三个字么?艾滋病不同感染期症状 

康生丹颗粒〈ksd〉对免疫抑制模型小鼠免疫功能影响实验研究-公布 

食疗与艾滋病研究-康生丹颗粒〈一〉 

艾滋病未来康复的动向分析 

艾滋病人的药膳 

首次公布康生丹提高艾滋病患者CD4的图片